Multiple sclerosis drug may raise JC virus antibody levels, leading to fatal

Multiple sclerosis drug may raise JC virus antibody levels, leading to fatal

Multiple sclerosis drug may raise JC virus antibody levels, leading to fatal
Multiple sclerosis drug may raise the risk of John Cunningham virus (JCV) resulting in a fatal brain infection. The study found that multiple sclerosis patients taking natalizumab may have a 10 times greater risk of developing a biomarker that …
Read more on Bel Marra Health

Multiple sclerosis drug tied to rising JC virus antibody levels
It is caused by the John Cunningham virus (JCV), a common virus usually kept under control by the immune system. But people with weakened immune systems, or on immunosuppressive drugs, are more susceptible to JCV-related problems. Natalizumab …
Read more on Science Daily

In memoriam: The legacies of John F. Kurtzke and Richard T. Johnson
His contributions to neurology, neuroepidemiology and MS research were widely regarded, and he was awarded the Dystel Prize for MS research in 1997 and the Charcot Award in 1999, in addition to the creation of the John F. Kurtzke Clinician–Scientist …
Read more on Nature.com

About the Author Robert